32.11MMarket Cap-1857P/E (TTM)
2.3817High2.2100Low17.92KVolume2.3817Open2.3600Pre Close40.91KTurnover0.18%Turnover RatioLossP/E (Static)14.53MShares6.789252wk High0.39P/B21.82MFloat Cap1.670052wk Low--Dividend TTM9.87MShs Float2869.9200Historical High--Div YieldTTM7.28%Amplitude1.6700Historical Low2.2820Avg Price1Lot Size
VYNE Therapeutics Stock Forum
VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202
Vyne Therapeutics Announces FDA Clearance of Ind Application for Vyn202, a Novel Bd2-Selective Bet Inhibitor
NEWS
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
GlobeNewswire· 5 mins ago
Dow Jones· 5 mins ago
No comment yet